Ticker Details
C4 Therapeutics, Inc.
IPO Date:	October 2, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$209.34M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.46 | 3.94%
Avg Daily Range (30 D):	$0.07 | 3.53%
Avg Daily Range (90 D):	$0.08 | 3.72%

Institutional Daily Volume
Avg Daily Volume:	1.45M
Avg Daily Volume (30 D):	1.42M
Avg Daily Volume (90 D):	1.61M

Trade Size
Avg Trade Size (Sh.):	151
Avg Trade Size (Sh.) (30 D):	220
Avg Trade Size (Sh.) (90 D):	214

Institutional Trades
Total Institutional Trades:	1,058
Avg Institutional Trade:	$1.96M
Avg Institutional Trade (30 D):	$6.73M
Avg Institutional Trade (90 D):	$3.5M
Avg Institutional Trade Volume:	.23M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.18M
Avg Closing Trade (30 D):	$1.93M
Avg Closing Trade (90 D):	$1.82M
Avg Closing Volume:	188.6K

News

Feb 4, 2026 @ 12:00 PM C4 Therapeutics to Participate in the Guggenheim E... Source: Na

Jan 14, 2026 @ 12:00 PM C4 Therapeutics Outlines Strategic Milestones to A... Source: C4 Therapeutics, Inc.

Nov 25, 2025 @ 12:00 PM C4 Therapeutics to Participate in the 8th Annual E... Source: C4 Therapeutics

Sep 15, 2025 @ 10:33 PM Why C4 Therapeutics Stock Crushed the Market on Mo... Source: Eric Volkman

May 7, 2025 @ 11:00 AM C4 Therapeutics Reports First Quarter 2025 Financi... Source: C4 Therapeutics

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.44	$-.37	$-.37
Diluted EPS	$-.44	$-.37	$-.37
Revenue	$11.23M	$6.46M	$7.24M
Gross Profit
Net Income / Loss	$-32.17M	$-26.02M	$-26.32M
Operating Income / Loss	$-34.41M	$-28.5M	$-29.16M
Cost of Revenue
Net Cash Flow	$-19.35M	$26.86M	$-4.21M
PE Ratio